{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:39:29Z","timestamp":1791362369742,"version":"4.3.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jaip.2022.03.008","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T21:52:36Z","timestamp":1648245156000},"page":"1974-1984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022"],"prefix":"10.1016","volume":"10","author":[{"given":"J.H.","family":"Butterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.03.008_bib1","first-page":"151","article-title":"Is cutaneous mastocytosis a reticulo-histiocytosis? Histological-clinical considerations regarding a case of urticaria pigmentosa sine pigmentatione","volume":"22","author":"Agostini","year":"1947","journal-title":"Dermosifilografo"},{"key":"10.1016\/j.jaip.2022.03.008_bib2","first-page":"360","article-title":"The morphology and behavior of mast cells obtained from mastocytomas and cultivated in\u00a0vitro","volume":"97","author":"Paff","year":"1947","journal-title":"Anat Rec"},{"key":"10.1016\/j.jaip.2022.03.008_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0091-6749(80)90114-1","article-title":"Physical urticaria\/angioedema: an experimental model of mast cell activation in humans","volume":"66","author":"Soter","year":"1980","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0736-4679(92)90527-Z","article-title":"Emergency medical recognition and management of idiopathic anaphylaxis","volume":"10","author":"Stoloff","year":"1992","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast cell activation syndromes and mastocytosis: initial treatment options and long-term management","volume":"7","author":"Castells","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.008_bib6","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jaip.2020.02.021","article-title":"The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome","volume":"8","author":"Butterfield","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.008_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0952-3278(91)90138-U","article-title":"Leukotriene C4 production by enriched human basophil preparations from normal and asthmatic subjects","volume":"44","author":"Van der Donk","year":"1991","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1016\/j.jaip.2022.03.008_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V29.5.722.722","article-title":"Release of histamine from human basophils","volume":"29","author":"Sampson","year":"1967","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.03.008_bib9","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1096\/fj.12-223867","article-title":"Histamine production by human neutrophils","volume":"27","author":"Alcaniz","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jaip.2022.03.008_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.iac.2007.09.004","article-title":"Urinary leukotriene E4","volume":"27","author":"Rabinovitch","year":"2007","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.jaip.2022.03.008_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/ajrccm.152.3.7663802","article-title":"Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma","volume":"152","author":"Wenzel","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib12","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1164\/ajrccm.161.5.9906068","article-title":"Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics","volume":"161","author":"Mackfarlane","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJM198012113032405","article-title":"Increased production of prostaglandin D2 in patients with systemic mastocytosis","volume":"303","author":"Roberts","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2019.1596800","article-title":"Recent advances in our understanding of mast cell activation\u2014or should it be mast cell mediator disorders?","volume":"15","author":"Theoharides","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaci.2005.06.007","article-title":"Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases","volume":"116","author":"Puxxeddu","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib16","first-page":"3928","article-title":"Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review","volume":"9","author":"Gulen","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.008_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.iac.2007.12.006","article-title":"Ocular mast cells and mediators","volume":"28","author":"Irani","year":"2008","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.jaip.2022.03.008_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multivaceted MRGPRX2: new insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib19","doi-asserted-by":"crossref","first-page":"676354","DOI":"10.3389\/fimmu.2021.676354","article-title":"MGRPRX2 and adverse drug reactions","volume":"12","author":"McNeil","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib121","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jaip.2022.03.007","article-title":"Personalized management strategies in mast cell disorders: ECNM-AIM user\u2019s guide for daily clinical practice","volume":"10","author":"Valent","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.008_bib21","first-page":"259","article-title":"Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase","volume":"1482","author":"Urade","year":"2000","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.jaip.2022.03.008_bib22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1074\/jbc.M706839200","article-title":"Tetranor PGDM, an abundant urinary metabolite reflects synthesis of PGD2 in mice and humans","volume":"283","author":"Song","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2022.03.008_bib23","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1073\/pnas.82.18.6030","article-title":"Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in\u00a0vivo in humans","volume":"82","author":"Liston","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2022.03.008_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0091-6749(96)70167-7","article-title":"Increased urinary excretion of the prostaglandin D2 metabolite 9\u03b1, 11\u03b2-PGF2 after aspirin challenge supports mast cell activation in aspirin induced airway obstruction","volume":"98","author":"O\u2019Sullivan","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/iid3.94","article-title":"Prostaglandin D2 metabolites as a biomarker of in\u00a0vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis","volume":"4","author":"Cho","year":"2016","journal-title":"Immunity Inflamm Dis"},{"key":"10.1016\/j.jaip.2022.03.008_bib26","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1111\/1523-1747.ep12468945","article-title":"Biochemical diagnosis of systemic mast cell disorders","volume":"96","author":"Roberts","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib27","first-page":"18","article-title":"The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production","volume":"26","author":"Kootte","year":"1983","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib28","first-page":"36","article-title":"Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope","volume":"95","author":"Roberts","year":"1982","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.jaip.2022.03.008_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000237133","article-title":"Cysteinyl leukotriene production in anaphylactic reactions","volume":"108","author":"Denzlinger","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2222.2008.03104.x","article-title":"Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis","volume":"39","author":"Ono","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1398-9995.2001.00913.x","article-title":"Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma","volume":"56","author":"Mita","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1183\/09031936.03.00113403","article-title":"Evidence of mast cell activation and leukotriene release after mannitol inhalation","volume":"22","author":"Brannan","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.03.008_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/all.14663","article-title":"Mediators of anaphylactic reactions: tryptase and histamine stability in whole blood","volume":"76","author":"Serrier","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/270530a0","article-title":"Role of prostaglandin-mediated vasodilatation in inflammation","volume":"270","author":"Williams","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2022.03.008_bib35","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1126\/science.287.5460.2013","article-title":"Prostaglandin D2 as a mediator of allergic asthma","volume":"287","author":"Matsuoka","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jaip.2022.03.008_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(99)01251-X","article-title":"CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)","volume":"459","author":"Nagata","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaip.2022.03.008_bib37","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1172\/JCI110938","article-title":"Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells","volume":"71","author":"Schleimer","year":"1984","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2022.03.008_bib38","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.129.4.1627","article-title":"Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE","volume":"129","author":"Lewis","year":"1982","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/clpt.1982.63","article-title":"Aspirin blocks nicotinic acid-induced flushing","volume":"11","author":"Wilkin","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2022.03.008_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in\u00a0vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"key":"10.1016\/j.jaip.2022.03.008_bib41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0091-6749(88)90968-2","article-title":"Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation","volume":"82","author":"Ormerod","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.prostaglandins.2009.01.001","article-title":"Survey of aspirin administration in systemic mastocytosis","volume":"88","author":"Butterfield","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaip.2022.03.008_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(57)91395-8","article-title":"Release of histamine in urticaria pigmentosa","volume":"269","author":"Hamrin","year":"1957","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.03.008_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archderm.1962.01590080087011","article-title":"Histamine liberation by codeine and polymyxin B in urticaria pigmentosa","volume":"86","author":"Sutter","year":"1962","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-6749(83)90098-2","article-title":"Intervention with epinephrine in hypotension associated with mastocytosis","volume":"71","author":"Turk","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib47","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/all.13445","article-title":"Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: the results of a double-blind, placebo-controlled challenge study","volume":"73","author":"Hermans","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4065\/70.5.481","article-title":"Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization","volume":"70","author":"Butterfield","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2022.03.008_bib49","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1523-1747.ep12606209","article-title":"Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2","volume":"104","author":"Morrow","year":"1995","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib50","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/all.12668","article-title":"Urinary 11\u03b2-PGF2\u03b1 and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders","volume":"70","author":"Divekar","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000144042","article-title":"Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D2 production","volume":"147","author":"Butterfield","year":"2008","journal-title":"Int Archs Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib52","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaip.2014.06.011","article-title":"Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24 hour urine 11beta prostaglandin2alpha","volume":"2","author":"Ravi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.008_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000503964","article-title":"Survey of mast cell mediator levels from patients presenting with symptoms of mast cell activation","volume":"181","author":"Butterfield","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-6749(94)90371-9","article-title":"Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation","volume":"93","author":"Awad","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib55","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4049\/jimmunol.117.4.1356","article-title":"Release of chemical mediators from partially purified human lung mast cells","volume":"117","author":"Patterson","year":"1976","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib56","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.131.4.1936","article-title":"Heterogenicity of human mast cells","volume":"131","author":"Schulman","year":"1983","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4049\/jimmunol.135.1.483","article-title":"Isolation and characterization of human intestinal mucosal mast cells","volume":"135","author":"Fox","year":"1985","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.138.3.861","article-title":"Human skin mast cells: their dispersion, purification, and secretory characterization","volume":"138","author":"Benyon","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib59","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.urology.2006.04.033","article-title":"Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis","volume":"68","author":"Lamale","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.jaip.2022.03.008_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2500\/108854186778995301","article-title":"Histamine in foods: its possible role in non-allergic adverse reactions to ingestants","volume":"7","author":"Malone","year":"1986","journal-title":"N\u00a0Engl Reg Allergy Proc"},{"key":"10.1016\/j.jaip.2022.03.008_bib61","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJM199103143241102","article-title":"Evidence that histamine is the causative toxin of scombroid-fish poisoning","volume":"324","author":"Morrow","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000007482","article-title":"Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors","volume":"59","author":"K\u00f6lby","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.jaip.2022.03.008_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anai.2013.09.017","article-title":"Stress triggers coronary mast cells leading to cardiac events","volume":"112","author":"Alevizos","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib64","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI113403","article-title":"Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release","volume":"81","author":"Schulman","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2022.03.008_bib65","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/1523-1747.ep12378589","article-title":"Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells","volume":"102","author":"EI-Lati","year":"1994","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000236568","article-title":"Specific activation of human mast cells by the ligand for c-Kit: comparison between lung, uterus and heart mast cells","volume":"102","author":"Sperr","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib67","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","article-title":"Histamine and histamine intolerance","volume":"85","author":"Maintz","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jaip.2022.03.008_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1043-6618(03)00009-4","article-title":"Histamine in the control of gastric acid secretion: a topic review","volume":"47","author":"Barocelli","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaip.2022.03.008_bib69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/clpt.2010.256","article-title":"Histamine: new thoughts about a familiar mediator","volume":"89","author":"Jones","year":"2011","journal-title":"Clin Pharmacol Therapeut"},{"key":"10.1016\/j.jaip.2022.03.008_bib70","first-page":"173","article-title":"The fate of released histamine","volume":"71","author":"Rangachari","year":"1998","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-4347(98)00481-2","article-title":"Determination of 1-methylhistamine and 1-ethylimidazoleacetic acid in human urine as a tool for the diagnosis of mastocytosis","volume":"721","author":"Martens-Lobenhoffer","year":"1999","journal-title":"J\u00a0Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.jaip.2022.03.008_bib72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jmb.2005.08.040","article-title":"Structural basis for inhibition of histamine N-methyltransferase by diverse drugs","volume":"353","author":"Horton","year":"2005","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaip.2022.03.008_bib73","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.anai.2010.08.005","article-title":"The basics of histamine biology","volume":"106","author":"Lieberman","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000050946","article-title":"Are adverse effects of sildenafil also caused by inhibition of diamine oxidase?","volume":"67","author":"Wantke","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.jaip.2022.03.008_bib75","doi-asserted-by":"crossref","first-page":"P23","DOI":"10.1186\/2045-7022-4-S3-P23","article-title":"Evaluation of the inhibitory effect of various drugs \/ active ingredients on the activity of human diamine oxidase in\u00a0vitro","volume":"4","author":"Leitner","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib76","series-title":"2013 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics","first-page":"S29","article-title":"Intestinal diamine oxidase: a potential new target for metformin","author":"Gupta","year":"2013"},{"key":"10.1016\/j.jaip.2022.03.008_bib77","doi-asserted-by":"crossref","DOI":"10.1007\/BF01983109","article-title":"Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects?","volume":"16","author":"Sattler","year":"1985","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2022.03.008_bib78","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0003-2697(84)90037-X","article-title":"Measurement of plasma histamine by stable isotope dilution gas chromatography-mass spectrometry: methodology and normal values","volume":"139","author":"Keyzer","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jaip.2022.03.008_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF01965099","article-title":"Concentration effect relationships of infused histamine in normal volunteers","volume":"12","author":"Ind","year":"1982","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2022.03.008_bib80","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9343(89)80398-5","article-title":"Analysis of plasma histamine levels in patients with mast cell disorders","volume":"87","author":"Friedman","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF01968812","article-title":"Biorhythmic changes of plasma histamine levels in healthy volunteers","volume":"22","author":"Rehn","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2022.03.008_bib82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-6749(95)70263-6","article-title":"Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma","volume":"96","author":"Asano","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12555351","article-title":"Studies on histamine metabolism in mastocytosis","volume":"80","author":"Granerus","year":"1983","journal-title":"J\u00a0Investig Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01965102","article-title":"Increased urinary methylimidazoleacetic acid (MelmAA) as an indicator of systemic mastocytosis","volume":"12","author":"Granerus","year":"1982","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2022.03.008_bib85","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archderm.1986.01660160078023","article-title":"The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid","volume":"122","author":"Ridell","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000234291","article-title":"Long-term follow-up of histamine turnover in mastocytosis","volume":"82","author":"Roupe","year":"1987","journal-title":"Intl Archs Allergy Appl Immun"},{"key":"10.1016\/j.jaip.2022.03.008_bib88","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.2012.02809.x","article-title":"Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions","volume":"67","author":"Van Doormaal","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib89","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/leu.2013.227","article-title":"Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2022.03.008_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124912","article-title":"Determination of plasma heparin level improves identification of systemic mast cell activation disease","volume":"10","author":"Vysniauskaite","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2022.03.008_bib91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib92","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1398-9995.1997.tb00966.x","article-title":"Measurements of leukotrienes in the urine: strategies and applications","volume":"52","author":"Kumlin","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.008_bib93","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199009063231006","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases","volume":"323","author":"Lewis","year":"1990","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jaip.2022.03.008_bib94","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.03.008_bib95","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1734-1140(10)70306-6","article-title":"Transcellular biosynthesis of eicosanoids","volume":"62","author":"Sala","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jaip.2022.03.008_bib96","first-page":"2504","article-title":"Comparative studies of human basophils and mast cells","volume":"42","author":"MacGlashan","year":"1983","journal-title":"Fed Proc"},{"key":"10.1016\/j.jaip.2022.03.008_bib97","first-page":"53","article-title":"Purified human basophils and mast cells: current concepts of mediator release","volume":"64","author":"Schulman","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.jaip.2022.03.008_bib98","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1172\/JCI110670","article-title":"Generation of leukotrienes by purified human lung mast cells","volume":"70","author":"MacGlashan","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2022.03.008_bib99","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1523-1747.ep12531738","article-title":"Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin","volume":"80","author":"Soter","year":"1983","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2022.03.008_bib100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clinbiochem.2016.02.007","article-title":"Analytical and clinical validation of an LC-MS\/MS method for urine leukotriene E4: a marker of systemic mastocytosis","volume":"49","author":"Lueke","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jaip.2022.03.008_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2021.106563","article-title":"Divergent PGD2 and leukotriene C4 metabolite excretion following aspirin therapy: ten patients with systemic mastocytosis","volume":"155","author":"Butterfield","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaip.2022.03.008_bib102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13223-021-00593-8","article-title":"Exercise-induced anaphylaxis unrelated to food ingestion and with hyperleukotrieneuria during challenge testing","volume":"17","author":"Motomura","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib103","first-page":"469","article-title":"The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis","volume":"62","author":"Raithel","year":"2011","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jaip.2022.03.008_bib104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2010.03.003","article-title":"Increased leukotriene E4 excretion in systemic mastocytosis","volume":"92","author":"Butterfield","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaip.2022.03.008_bib105","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.3390\/ijms21239030","article-title":"Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine","volume":"21","author":"Valent","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2022.03.008_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib107","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaip.2022.03.008_bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3324\/haematol.2019.234864","article-title":"Kit D816V and the cytokine storm in mastocytosis: production and role of interleukin-6","volume":"105","author":"Valent","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2022.03.008_bib109","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/cyto.2002.2010","article-title":"IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells","volume":"20","author":"Kikuchi","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.jaip.2022.03.008_bib110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1067\/mai.2002.120524","article-title":"Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase","volume":"109","author":"Brockow","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib111","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000063858","article-title":"Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients","volume":"128","author":"Theoharides","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib112","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","article-title":"IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis","volume":"115","author":"Brockow","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.008_bib113","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","volume":"30","author":"Mayado","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2022.03.008_bib114","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3324\/haematol.2018.212126","article-title":"Oncogenic D816Vsignaling in mast cells causes persistent IL-6 production","volume":"105","author":"Tobio","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2022.03.008_bib115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","article-title":"Bleeding diathesis in patients with mast cell activation disease","volume":"106","author":"Seidel","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2022.03.008_bib116","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1076029607309173","article-title":"Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis","volume":"14","author":"Sucker","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jaip.2022.03.008_bib117","first-page":"1","article-title":"A\u00a0French national survey on clotting disorders in mastocytosis","volume":"94","author":"Carvalosa","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jaip.2022.03.008_bib118","first-page":"283","article-title":"Primary hyperfibrinogenolysis in a patient with anaphylactic shock","volume":"79","author":"Mazzi","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2022.03.008_bib119","first-page":"164","article-title":"Isolated prolongation of activated partial thromboplastin time following wasp sting","volume":"46","author":"Wang","year":"2005","journal-title":"Acta Paediatr Taiwan"},{"key":"10.1016\/j.jaip.2022.03.008_bib120","doi-asserted-by":"crossref","first-page":"1176.e1","DOI":"10.1016\/j.ajem.2009.02.005","article-title":"\u201cHeparinization\u201d and hyperfibrinogenolysis by wasp sting","volume":"27","author":"Lombardini","year":"2009","journal-title":"Am J Emerg Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822002823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822002823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:33:36Z","timestamp":1761975216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2213219822002823"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.03.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}